BioCryst Pharmaceuticals Stock Options
| BCRX Stock | USD 4.16 0.05 1.19% |
BioCryst Pharmaceuticals' option chain provides insight into all available option contracts written on BioCryst Pharmaceuticals' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of BioCryst Pharmaceuticals' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given BioCryst option contract.
In The Money vs. Out of Money Option Contracts on BioCryst Pharmaceuticals
Analyzing BioCryst Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in BioCryst Pharmaceuticals regardless of its overall volatility. This is especially true when BioCryst Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money BioCryst Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with BioCryst Pharmaceuticals' stock while costing only a fraction of its price.
BioCryst Pharmaceuticals' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 82.06 with a put-to-call open interest ratio of 0.65 over 20 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 25, with calls trading at the volume of 112. This yields a 0.22 put-to-call volume ratio. The BioCryst Pharmaceuticals option chain provides detailed quote and price information for the current BioCryst Pharmaceuticals option contracts. It shows all of BioCryst Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
BioCryst Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in BioCryst Pharmaceuticals' lending market. For example, when BioCryst Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on BioCryst Pharmaceuticals, he or she must hedge the risk by shorting BioCryst Pharmaceuticals stock over its option's life.
2024-05-17
The chart above shows BioCryst Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. BioCryst Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for BioCryst Pharmaceuticals' option, there is no secondary market available for investors to trade.
BioCryst Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of BioCryst Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell BioCryst stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If BioCryst Pharmaceuticals' stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioCryst Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. Please note that buying 'in-the-money' options on BioCryst Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if BioCryst Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money BioCryst Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if BioCryst Stock moves the wrong way.
At this time, BioCryst Pharmaceuticals' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 542.8 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (432.8 M). BioCryst Pharmaceuticals In The Money Call Balance
When BioCryst Pharmaceuticals' strike price is surpassing the current stock price, the option contract against BioCryst Pharmaceuticals stock is said to be in the money. When it comes to buying BioCryst Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on BioCryst Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
BioCryst Current Options Market Mood
BioCryst Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps BioCryst Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of BioCryst Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. BioCryst Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current BioCryst Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current BioCryst contract
Base on the Rule 16, the options market is currently suggesting that BioCryst Pharmaceuticals will have an average daily up or down price movement of about 5.13% per day over the life of the 2024-05-17 option contract. With BioCryst Pharmaceuticals trading at USD 4.16, that is roughly USD 0.21. If you think that the market is fully incorporating BioCryst Pharmaceuticals' daily price movement you should consider buying BioCryst Pharmaceuticals options at the current volatility level of 82.06%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
BioCryst |
Purchasing BioCryst Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" BioCryst calls. Remember, the seller must deliver BioCryst Pharmaceuticals stock to the call owner when a call is exercised.
BioCryst Pharmaceuticals Option Chain
When BioCryst Pharmaceuticals' strike price is surpassing the current stock price, the option contract against BioCryst Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
BioCryst Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on BioCryst. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for BioCryst. It also shows strike prices and maturity days for a BioCryst Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $2.0 | 0.8963 | 0.027 | 0 | 2024-05-17 | 1.0 - 5.0 | 0.0 | In |
Call | 2024-05-17 CALL at $3.0 | 0.8658 | 0.028 | 0 | 2024-05-17 | 0.95 - 4.9 | 0.0 | In |
Call | 2024-05-17 CALL at $4.0 | 0.6246 | 0.4827 | 327 | 2024-05-17 | 0.35 - 0.55 | 0.4 | In |
Call | 2024-05-17 CALL at $5.0 | 0.1907 | 0.3499 | 1661 | 2024-05-17 | 0.05 - 0.1 | 0.06 | Out |
Call | 2024-05-17 CALL at $6.0 | 0.1059 | 0.167 | 1361 | 2024-05-17 | 0.0 - 0.05 | 0.05 | Out |
Put | 2024-05-17 PUT at $4.0 | -0.371 | 0.5339 | 1395 | 2024-05-17 | 0.15 - 0.25 | 0.2 | Out |
Put | 2024-05-17 PUT at $5.0 | -0.4601 | 0.1343 | 813 | 2024-05-17 | 0.7 - 2.75 | 0.95 | In |
Put | 2024-05-17 PUT at $6.0 | -0.5011 | 0.1128 | 1 | 2024-05-17 | 1.55 - 3.9 | 0.8 | In |
Put | 2024-05-17 PUT at $7.0 | -0.5129 | 0.0973 | 0 | 2024-05-17 | 2.65 - 4.9 | 0.0 | In |
Put | 2024-05-17 PUT at $8.0 | -0.5488 | 0.0929 | 0 | 2024-05-17 | 3.6 - 5.8 | 0.0 | In |
Put | 2024-05-17 PUT at $9.0 | -0.5475 | 0.0846 | 0 | 2024-05-17 | 4.6 - 6.9 | 0.0 | In |
Put | 2024-05-17 PUT at $10.0 | -0.646 | 0.0895 | 0 | 2024-05-17 | 5.6 - 7.3 | 0.0 | In |
BioCryst Pharmaceuticals Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
BioCryst Pharmaceuticals Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
BioCryst Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioCryst Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
BioCryst Pharmaceuticals Corporate Directors
BioCryst Pharmaceuticals corporate directors refer to members of a BioCryst Pharmaceuticals board of directors. The board of directors generally takes responsibility for the BioCryst Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BioCryst Pharmaceuticals' board members must vote for the resolution. The BioCryst Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Stanley Erck | Independent Director | Profile | |
| Robert Ingram | Director | Profile | |
| Charles Sanders | Independent Director | Profile | |
| Kenneth Lee | Independent Director | Profile |
Already Invested in BioCryst Pharmaceuticals?
The danger of trading BioCryst Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BioCryst Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BioCryst Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BioCryst Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether BioCryst Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioCryst Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biocryst Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biocryst Pharmaceuticals Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioCryst Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy BioCryst Stock please use our How to Invest in BioCryst Pharmaceuticals guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for BioCryst Stock analysis
When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is BioCryst Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioCryst Pharmaceuticals. If investors know BioCryst will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioCryst Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.18) | Revenue Per Share 1.724 | Quarterly Revenue Growth 0.174 | Return On Assets (0.12) | Return On Equity (19.25) |
The market value of BioCryst Pharmaceuticals is measured differently than its book value, which is the value of BioCryst that is recorded on the company's balance sheet. Investors also form their own opinion of BioCryst Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is BioCryst Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioCryst Pharmaceuticals' market value can be influenced by many factors that don't directly affect BioCryst Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioCryst Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioCryst Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioCryst Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.